Ensysce Biosciences, Inc. short interest in 2022
In 2022, Ensysce Biosciences, Inc.'s disclosed short interest ran from 0.44% of shares outstanding on 14 Jan 2022 to 1.87% on 14 Oct 2022, a change of +1.43 percentage points. The year's high was 4.29% on 15 Sep 2022 and its low 0.35% on 13 May 2022, averaging 1.56% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.15 days on 14 Oct 2022. Full history: Ensysce Biosciences, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 0.44% (14 Jan 2022)
- End of year
- 1.87% (14 Oct 2022)
- Change
- +1.43 pp
- High
- 4.29% (15 Sep 2022)
- Low
- 0.35% (13 May 2022)
- Average
- 1.56%
- Highest days to cover
- 2.15 (14 Oct 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 0.44% | 1.00 | |
| 15 Feb 2022 | 0.58% | 1.00 | |
| 15 Mar 2022 | 0.53% | 1.00 | |
| 31 Mar 2022 | 1.04% | 1.00 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 1.47% | 1.00 | |
| 29 Apr 2022 | 2.42% | 1.11 | |
| 13 May 2022 | 0.35% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2022 | 0.68% | 1.00 | |
| 15 Jun 2022 | 1.04% | 1.00 | |
| 30 Jun 2022 | 1.51% | 1.00 | |
| 15 Jul 2022 | 1.81% | 1.00 | |
| 29 Jul 2022 | 1.59% | 2.03 | |
| 15 Aug 2022 | 1.92% | 1.32 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 1.83% | 1.00 | |
| 15 Sep 2022 | 4.29% | 1.00 | |
| 30 Sep 2022 | 3.11% | 1.01 | |
| 14 Oct 2022 | 1.87% | 2.15 |
See also: Ensysce Biosciences, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.